Kimberly Schluns

Associate Professor

  • 7797 Citations
  • 28 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kimberly Schluns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Interleukin-15 Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
T-cells Chemical Compounds
Interleukin-15 Receptors Medicine & Life Sciences
Cytokines Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences
Vaccination Medicine & Life Sciences
Interleukin-17 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

1 Citation (Scopus)

IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses

Santana Carrero, R. M., Beceren-Braun, F., Rivas, S. C., Hegde, S. M., Gangadharan, A., Plote, D., Pham, G., Anthony, S. M. & Schluns, K., Jan 8 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 2, p. 599-608 10 p.

Research output: Contribution to journalArticle

Interleukin-15
Tumor Microenvironment
Neoplasms
Immunity
Tumor-Infiltrating Lymphocytes

Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation

Plote, D., Choi, W., Mokkapati, S., Sundi, D., Ferguson, J. E., Duplisea, J., Parker, N. R., Yla-Herttuala, S., Committee, SUO. CTC. B., McConkey, D., Schluns, K. & Dinney, C. P., May 4 2019, In : OncoImmunology. 8, 5, e1577125.

Research output: Contribution to journalArticle

Open Access
Interferon Type I
Carcinoma
Neoplasms
Interleukin-6
Monoclonal Antibodies
1 Citation (Scopus)

The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming

Zhou, X., Yu, J., Cheng, X., Zhao, B., Manyam, G. C., Zhang, L., Schluns, K., Li, P., Wang, J. & Sun, S-C., Jul 1 2019, In : Nature Immunology. 20, 7, p. 879-889 11 p.

Research output: Contribution to journalArticle

Interleukin-15
Natural Killer Cells
T-Lymphocytes
CD27 Antigens
Ubiquitin
1 Citation (Scopus)

The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside

Duplisea, J. J., Mokkapati, S., Plote, D., Schluns, K., McConkey, D. J., Yla-Herttuala, S., Parker, N. R. & Dinney, C. P., Oct 1 2019, In : World journal of urology. 37, 10, p. 2041-2049 9 p.

Research output: Contribution to journalReview article

Mycobacterium bovis
Urinary Bladder Neoplasms
Genetic Therapy
Interferons
Urinary Bladder
15 Citations (Scopus)

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy

Hailemichael, Y., Woods, A., Fu, T., He, Q., Nielsen, M. C., Hasan, F., Roszik, J., Xiao, Z., Vianden, C., Khong, H., Singh, M., Sharma, M., Faak, F., Moore, D., Dai, Z., Anthony, S. M., Schluns, K., Sharma, P., Engelhard, V. H. & Overwijk, W., Apr 2 2018, In : Journal of Clinical Investigation. 128, 4, p. 1338-1354 17 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Cytotoxic T-Lymphocytes
Ligands
Vaccination
Proteins